Detalles de la búsqueda
1.
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Cancer
; 117(20): 4671-8, 2011 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21671479
2.
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
Int J Radiat Oncol Biol Phys
; 64(2): 382-91, 2006 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16213104
3.
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
Int J Oncol
; 28(5): 1141-51, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16596230
4.
Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
Int J Radiat Oncol Biol Phys
; 96(1): 21-9, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27511844
5.
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
J Clin Oncol
; 21(2): 320-6, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12525525
6.
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
Int J Radiat Oncol Biol Phys
; 61(4): 1096-106, 2005 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15752889
7.
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Clin Cancer Res
; 10(15): 4922-32, 2004 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15297392
8.
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Clin Cancer Res
; 9(16 Pt 1): 5936-43, 2003 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14676118
9.
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Clin Cancer Res
; 9(5): 1689-97, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12738722
10.
Understanding stereotactic radiosurgery for intracranial tumors, seed implants for prostate cancer, and intravascular brachytherapy for cardiac restenosis.
Cancer Nurs
; 26(6): 494-502, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15022981
11.
Lymph node density--prognostic value in head and neck cancer.
Head Neck
; 36(2): 266-72, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23765406
12.
Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.
J Geriatr Oncol
; 4(4): 327-33, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24472475
13.
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Oral Oncol
; 48(10): 1025-1030, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22621836
14.
Outcomes in black patients with early breast cancer treated with breast conservation therapy.
Int J Radiat Oncol Biol Phys
; 79(2): 392-9, 2011 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20434849
15.
Chemoreirradiation for recurrent salivary gland malignancies.
Radiother Oncol
; 95(3): 308-11, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20385414
16.
Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
Radiother Oncol
; 97(2): 318-21, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20934766
17.
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.
Head Neck
; 32(11): 1519-27, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20187015
18.
Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.
Arch Otolaryngol Head Neck Surg
; 136(12): 1226-34, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21173372
19.
Predictors of competing mortality in advanced head and neck cancer.
J Clin Oncol
; 28(1): 15-20, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19933920
20.
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
J Clin Oncol
; 28(20): 3336-43, 2010 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20498391